Literature DB >> 22381180

Toxicology of frequently encountered nonsteroidal anti-inflammatory drugs in dogs and cats.

Safdar A Khan1, Mary Kay McLean.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a group of heterogeneous compounds extensively used in both human and veterinary medicine for their antipyretic, anti-inflammation, and analgesic properties. NSAIDs consist of a wide range of pharmacologically active agents with different chemical structures, with similar therapeutic and adverse effects. The ASPCA Animal Poison Control Center received 22,206 NSAID incidents in dogs and cats (3% of total cases; dogs [15,823] and cats [1244]) during 2005 to 2010. This is roughly equivalent to 4% NSAID incidents reported in humans. The most common NSAID involved was ibuprofen, followed by aspirin, naproxen, deracoxib, meloxicam, diclofenac, piroxicam, indomethacin, nabumetone, and etodolac. This article provides a brief overview of classification, mechanism of action, pharmacologic and toxicologic properties, and treatment information involving frequently encountered human and veterinary NSAIDs in dogs and cats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381180     DOI: 10.1016/j.cvsm.2012.01.003

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  11 in total

Review 1.  An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures.

Authors:  George J Dugbartey; Luke J Peppone; Inge A M de Graaf
Journal:  Toxicology       Date:  2016-10-04       Impact factor: 4.221

2.  Acute nephrotic-range glomerular proteinuria following ibuprofen intoxication in two cats.

Authors:  Yaiza Herrero; Claudia Iannucci; Nora Schreiber; Bernard D Hansen; Alessio Vigani
Journal:  JFMS Open Rep       Date:  2022-06-21

3.  Comparing the prevalence of tetrahydrocannabinol (THC) toxicities in dogs before and after legalization of cannabis in Canada.

Authors:  Molly Joffe; Daniel Joffe
Journal:  Can Vet J       Date:  2020-09       Impact factor: 1.008

4.  Dermal cell damage induced by topical application of non-steroidal anti-inflammatory drugs is suppressed by trehalose co-lyophilization in ex vivo analysis.

Authors:  Yuko Kayasuga-Kariya; Shintaroh Iwanaga; Ayano Fujisawa; Lee-Shuan Lin; Shigeki Suzuki; Ung-Il Chung; Nobuo Sasaki; Nobuyuki Shimohata; Manabu Mochizuki
Journal:  J Vet Med Sci       Date:  2013-07-24       Impact factor: 1.267

5.  Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations.

Authors:  Céline E Toutain; Patrick Brossard; Stephen B King; Rainer Helbig
Journal:  BMC Vet Res       Date:  2018-08-17       Impact factor: 2.741

6.  Use of therapeutic plasma exchange to treat nonsteroidal anti-inflammatory drug overdose in dogs.

Authors:  Melisa G Rosenthal; Mary A Labato
Journal:  J Vet Intern Med       Date:  2019-01-30       Impact factor: 3.333

7.  Treatment of a massive naproxen overdose with therapeutic plasma exchange in a dog.

Authors:  Kathleen Kicera-Temple; Leonel Londoño; Travis M Lanaux; Gareth J Buckley
Journal:  Clin Case Rep       Date:  2019-06-28

8.  Detection and dynamics of anti-platelet antibodies in thrombocytopenic dogs with and without idiopathic immune thrombocytopenia.

Authors:  Sarah Shropshire; Steven Dow; Michael Lappin
Journal:  J Vet Intern Med       Date:  2020-02-18       Impact factor: 3.333

Review 9.  Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma.

Authors:  Walaa Hamed Shaker Nasry; Chelsea K Martin
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

10.  CD147 and Cyclooxygenase Expression in Feline Oral Squamous Cell Carcinoma.

Authors:  Walaa Hamed Shaker Nasry; Haili Wang; Kathleen Jones; Wessel P Dirksen; Thomas J Rosol; Juan Carlos Rodriguez-Lecompte; Chelsea K Martin
Journal:  Vet Sci       Date:  2018-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.